Article citationsMore>>

U. S. Food and Drug Administration (2014) Removing Retrievable Inferior Vena Cava Filters: FDA Safety Communication. U. S. Food and Drug Administration.

has been cited by the following article:

• TITLE: Delayed Lumbar Artery Laceration and Symptomatic Retroperitoneal Hemorrhage Following IVC Filter Placement

  AUTHORS: Jennifer P. Montgomery, Kenneth J. Kolbeck

  KEYWORDS: Inferior Vena Cava Filter, Pulmonary Embolism, Hemorrhage, Arterial Embolization, Lumbar Artery Laceration

  JOURNAL NAME: Open Journal of Radiology, Vol.5 No.4, December 10, 2015

  ABSTRACT: Inferior vena cava filters are placed in selected patients to protect against potentially fatal pulmonary embolism. Generally, filter placement is regarded as a safe procedure although rare complications may arise. Recurrent thromboembolic events are the most common complications assoiated with inferior vena cava filters; however, there are multiple reports of filter fracture, migration, embolization, penetration and perforation. The aim of this report is to illustrate a serious potential complication of inferior vena cava filters. We report a rare case of symptomatic retroperitoneal hemorrhage occurring 3 weeks after filter placement treated successfully with selective arterial embolization of a lumbar artery laceration. This case serves to highlight the importance of retrieving filters when they are no longer beneficial.